G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 221,249 | 212,152 | 244,086 | 279,093 | 207,369 |
| Receivables | 5,688 | 5,240 | 4,962 | 5,048 | 237 |
| Inventories | 3,471 | 1,375 | 1,402 | 1,427 | N/A |
| TOTAL | $243,565 | $232,983 | $265,700 | $297,012 | $216,392 |
| Non-Current Assets | |||||
| PPE Net | 2,013 | 2,127 | 2,244 | 2,362 | 2,482 |
| Other Non-Current Assets | 8,516 | 8,387 | 8,811 | 9,184 | 9,678 |
| TOTAL | $10,529 | $10,514 | $11,055 | $11,546 | $12,160 |
| Total Assets | $254,094 | $243,497 | $276,755 | $308,558 | $228,552 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,897 | 3,577 | 3,638 | 4,783 | 3,572 |
| Accrued Expenses | 23,180 | 22,013 | 18,566 | 18,075 | 16,486 |
| Other current liabilities | 1,505 | 1,223 | 3,252 | 2,592 | 3,148 |
| TOTAL | $27,613 | $26,839 | $25,641 | $25,604 | $23,443 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,190 | 30,273 | 30,093 | 29,913 | 19,893 |
| Deferred Revenues | 31 | 26 | 185 | 154 | 237 |
| Other Non-Current Liabilities | 6,750 | 7,046 | 7,325 | 7,598 | 7,865 |
| TOTAL | $82,940 | $38,319 | $37,918 | $37,511 | $27,758 |
| Total Liabilities | $110,553 | $65,158 | $63,559 | $63,115 | $51,201 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,706 | 42,522 | 42,348 | 42,074 | 41,959 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -584,459 | -544,439 | -501,971 | -462,549 | -436,107 |
| Other shareholders' equity | -8 | -8 | -8 | -8 | -8 |
| TOTAL | $143,541 | $178,339 | $213,196 | $245,443 | $177,351 |
| Total Liabilities And Equity | $254,094 | $243,497 | $276,755 | $308,558 | $228,552 |